Facebook Linkedin Mail Twitter Youtube
Facebook Linkedin Mail Twitter Youtube
    Latest

    Latest News

    BioVentrix resumes ALIVE trial after COVID-19 pause

    ESC 2020 Congress: ISCHEMIA trial suggests invasive approach benefits high risk patients

    ESC 2020 Congress: No discernible effect on saphenous vein graft patency from adding ticagrelor to aspirin after CABG

    Philips launches latest version of its Azurion imaging platform

    Miracor secures financing to support PiCSO clinical study

    ESC 2020 Congress: AF associated with long-term mortality in primary PCI patients regardless of LV function

    ESC 2020 Congress: POPular TAVI findings point to aspirin-only antiplatelet strategy

    ESC Congress 2020: Mavacamten improves heart function in HCM patients

    ESC 2020 Congress: TMVR with Tendyne results in favourable LV remodelling

    ESC Congress 2020: Society publishes new guidelines on congenital heart disease, non-ST-segment elevation ACS

    ESC 2020 Congress: EMPEROR-Reduced finds reduced mortality risk in HFrEF patients using empagliflozin

    FDA approves revised labelling for Medtronic’s Evolut valve

    CX Aortic Vienna

    Inaugural CX Aortic Vienna to take place online

    Philips expands cardiovascular ultrasound portfolio with Affiniti CVx

    coronary artery bypass

    AHA issues guidance on stroke prevention in heart surgery patients

    Heart Rhythm Society publishes Cardiovascular Digital Health Journal

    Chinese study suggests STEMI patients had increased mortality risk during COVID-19 pandemic

    Heart teams and interventional cardiologists often differ over recommendations for multivessel CAD

    Women “underrepresented” in heart failure studies

    Transcatheter tricuspid valve replacement “low risk” for complications

    Philips introduces Omniwire for coronary artery procedures

    Cardiovascular risk factors linked to COVID-19 complications and death

    10-year data on VIVO ISAR drug-eluting stent published in JACC

    Stress may have clinical implications for heart failure patients

    Biosensors announces enrolment of first patient in REFORM pivotal trial

    Survey reveals patient attitudes to heart valve procedures

    InnovHeart secures US$24 million finance package

    JAHA retracts paper calling for end to cardiology diversity programmes

    FORWARD PRO study of Evolut Pro valve meets safety and efficacy goals

    CardioMech secures financing for mitral valve repair study

    Meta-analysis advocates “personalised approach” to DAPT duration after PCI

    Eko and AstraZeneca announce digital cardiovascular health partnership

    FDA issues EUA for left-sided Impella to provide left ventricular unloading

    Frankfurt study finds high rate of cardiac complications in recovered COVID-19 patients

    Japanese study finds high survival rates with use of Impella heart pump

    Sapien 3

    Low one-year rate of mortality found in mitral valve-in-valve replacement using Sapien 3

    Keystone Heart announces first case using TriGUARD 3 CEP device

    NSAIDs increase bleeding risk after myocardial infarction, Korean study finds

    American College of Cardiology to launch JACC: Asia

    Abiomed gains approval for data streaming from the Impella console

    TAVI or surgical valve replacement “similarly effective” in men and women

    Caption Health gains FDA approval for updates to its cardiac AI system

    Mavacamten granted Breakthrough Therapy Designation

    Funding secured to further study of AI systems for cardiovascular health

    Genetic testing could aid decision-making in cardiovascular healthcare

    Race and gender bias may impact the timing of treatment for heart failure patients

    Inspiron sirolimus eluting stent receives CE mark approval

    Next-generation Watchman LAAC device gains US FDA approval

    LifeSignals receives US FDA clearance for the ECG Remote Monitoring Patch

    LivaNova launches Perceval Plus sutureless heart valve in Europe

    Women taking beta blockers for hypertension may have higher risk of heart failure with acute coronary syndrome

    Fall in hospitalisations for acute coronary syndrome seen during COVID-19

    FDA approval for Edwards Lifesciences’ KONECT RESILIA aortic valved conduit

    AHA Scientific Sessions 2020 to be held virtually

    Half of COVID-19 patients receiving echocardiograms show heart abnormalities

    FDA grants Breakthrough Device Designation for Doraya temporary catheter

    ACIST Medical Systems announces launch of Navvus II Rapid Exchange FFR microcatheter

    Venus Medtech and Pi-Cardia to bring Leaflex catheter to Chinese market

    EAPCI issues consensus statement on ischaemia with non-obstructive coronary arteries

    First 10-year report of TAVI durability indicates a low rate of structural valve deterioration

    Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress

    First coronary patient enrolled in FDA IDE study of drug eluting balloon

    Woman patient

    Black patients have higher rates of death after PCI

    Ancora Heart receives IDE approval for study of AccuCinch

    American Heart Association appoints Mitchell Elkind as president

    NuVera announces successful first-in-human use of NuVision ICE catheter

    A higher volume of mitral valve repair procedures is associated with lower mortality rates

    Morning exercise is the key to a good night’s sleep after heart bypass surgery

    Carag Bioresorbable Septal Occluder approved for US IDE trial

    PCR e-Course 2020: Two-year outcomes of deferred revascularisation based on FFR or iFR measurements “virtually identical”

    PCR e-Course 2020: P2Y12 inhibitor monotherapy associated with increased risk of cardiac death after PCI

    PCR e-Course 2020: Roll-in trial finds high device success rate for Amplatzer Amulet occlusion device

    MedAlliance gains CE mark for coronary Selution SLR sirolimus drug eluting balloon

    CardiAMP Heart Failure Trial continues with first patient randomised in Covid-19 era

    PCR e-Course 2020: Bicuspid TAVI is feasible, safe and efficient

    PCR e-Course 2020: Data for Ultimaster reinforce safety and efficacy of device

    PCR e-Course 2020: Cangrelor provided inferior inhibitor of platelet aggregation than tirofiban in STEMI patients

    PCR e-Course 2020: CoFI system may address microvascular obstruction after primary PCI

    PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes vs NOACs in high risk AF patients

    PCR e-Course 2020: Routine revascularisation confers no survival advantage over initial medical therapy in patients with stable disease

    PCR e-Course 2020: Reduction in tricuspid regurgitation with TriClip edge-to-edge repair is sustained at one year

    PCR e-Course 2020: DynamX Bioadaptor shows “excellent” safety and efficacy at 12 months

    PCR e-Course 2020: DEFINITION II finds two-stent approach better than provisional in complex lesions

    PCR e-Course 2020: Sham patients from RADIANCE-HTN SOLO who crossed over to denervation had reduced blood pressure

    PCR e-Course 2020: Evolut Low-Risk trial confirms TAVI is non-inferior to surgery, and establishes it is cost-effective

    First evaluation of long-term outcomes after aortic valve-in-valve presented at PCR e-Course 2020

    PCR e-Course 2020: Evoque demonstrates feasibility for mitral valve replacement via a transseptal approach

    PCR e-Course 2020: Mitral valve-in-valve and valve-in-ring strategies often require repeat procedures

    ACC and SVS Join Forces on Single Vascular Registry

    Miracor Medical’s PiCSO System receives CE mark

    Evolut gets CE mark in low-risk patients and new labelling for bicuspid use

    Smartphone app uses can identify lung congestion in heart failure patients

    Proximo Medical and Coala Life announce partnership for US markets

    Abiomed initiates online education platform for PCI

    IC fellows’ training has been affected by pandemic

    Blue Sail Medical and Biosensors International acquire TAVI company NVT

    MicroPort obtains CE mark for PathBuilder

    British Heart Foundation calls for urgent resumption of routine services for heart and circulatory diseases

    FDA issues IDE for Impella ECP and EUA for Impella RP

    Keith Oldroyd to become CMO at Biosensors

    A coordinated strategy provides the best outcomes for aortic arch treatment

    Resolute Onyx becomes first and only drug-eluting stent in Europe to have one-month DAPT indication for high bleeding risk patients

    Bicuspid TAVI outcomes as good as those for tricuspid

    ACC launches summer COVID-19 education series

    ESC to stream the latest science in heart failure

    EXCEL: PCI inferior to CABG in Bayesian reanalysis

    PERSIST-AVR study on Perceval sutureless aortic valve presented at AATS

    CeloNova completes enrolment in first 14-day DAPT randomised controlled trial

    COVID-19: TCT becomes latest conference to go virtual

    Limited health literacy associated with a higher risk of death in heart failure patients

    Society of Cardiovascular Computed Tomography to present gold medal award to John Lesser

    COVID-19: NHS staff show signs of mild depression

    SCAI 2020: PROTECT III shows placing Impella prior to high-risk PCI associated with lower mortality

    Jeffrey J Popma joins Medtronic as vice president and chief medical officer for coronary, renal denervation, and structural heart businesses

    CE mark PASCAL clip-based system for transcatheter tricuspid repair

    Robotic PCI associated with a 20% reduction in radiation exposure

    SCAI 2020: Strong 10-year performance for Melody transcatheter pulmonary valve

    Risk factors for cardiovascular disease linked to cognitive decline

    Eating is no less safe than fasting prior to cardiac catheterisation

    SCAI 2020: Statin therapy plus icosapent ethyl significantly reduces number first and repeat revascularisation

    SCAI 2020: Telemedicine could be used offer remote guidance to STEMI patients

    PCR announce dates for its online course

    SCAI release positional statement on optimal PCI for complex coronary artery disease

    MedAlliance gains CE mark approval for coronary Selution SLR balloon

    Cardiothoracic surgeons are “extremely satisfied” with their jobs

    COVID-19: NCDR Chest Pain-MI, CathPCI registries to review effect of virus on heart disease patients

    Philips gains FDA clearance for the use of its ultrasound portfolio to manage COVID-19 cardiac complications

    FDA approves update to cardiac imaging system to aid COVID-19 diagnostics

    Resolute Onyx matches Orsiro at two years in all-comers’ patients

    COVID-19: Heart Valve Voice US raises concerns about lack of patient input in recent guidance on restarting elective procedures

    COVID-19: Mayo Clinic works with Ultromics to rapidly assess patients with COVID

    Positive preclinical results supporting investigational new drug application for anti-inflammatory cell therapy for heart failure

    COVID-19: Anticoagulants may improve survival among hospitalised COVID patients

    Boston Scientific announces positive PINNACLE FLX study results

    COVID-19: Survey suggests increased operating days may be required to clear elective backlog

    COVID-19: ESC Congress 2020 to become a completely virtual event

    Study establishes safety and efficacy of ticagrelor monotherapy in acute coronary syndrome patients treated with Orsiro

    CE mark for SuperSaturated oxygen therapy

    COVID-19: Society of Cardiovascular Computed Tomography to host virtual meeting

    COVID-19: North American societies provide advice on resuming cardiovascular procedures

    complete-revascularisation

    The top three symptoms of myocardial infarction are same for women and men

    LifeSignals receives CE mark for the ECG Remote Monitoring Patch

    Wearable necklace-ECG can detect abnormal heart rhythm

    COVID-19: PCR officially cancel EuroPCR 2020

    Multivessel PCI has similar outcomes to culprit-vessel only PCI for cardiogenic shock patients when mechanical circulatory support used

    COVID-19: Calls for physicians to address domestic violence during social distancing

    Abiomed acquires novel ECMO developer Breethe

    American Academy of Neurology recommends PFO closure for selected stroke patients

    COVID-19: CMS outlines recommendations for restarting non-emergent procedures

    Cardiovascular robotics company secures €40 million series C financing round

    iRhythm offers home enrolment of Zio monitoring devices

    Boston Scientific reveals CE mark for Acurate neo 2 in Q1 financial results report

    COVID-19: SCAI and CAIC launch registry to provide vital data for managing patients

    COVID-19: BHF and NIHR work together to understand why cardiovascular increases risk of virus

    FDA Breakthrough Device Designation for novel heart failure therapy

    COVID-19: LivaNova can modify indications of its cardiopulmonary products to help address virus

    COVID-19: US societies release joint consensus statement on treating myocardial infarction during the pandemic

    COVID-19: Ventilator manufacturers unite to training alliance and create app for frontline workers

    COVID-19: Terumo BCT’s Mirasol shows efficacy against virus in plasma and platelets

    Pi-Cardia closes a US$27 million financing round led by Sofinnova Partners

    Proximo Medical named as commercialisation partner for Elucid Bioimaging

    COVID-19: Testing for high-sensitivity cardiac troponin would be beneficial not a hindrance

    COVID-19: “Essential” vs. “non-essential” TAVI procedures can be difficult to determine

    Study affirms safety and efficacy of Optimizer system for heart failure

    Pressing on abdomen helped to improve “STEMI” symptoms in rare case

    COVID-19: FDA authorise blood purification device for treating virus

    Woman patient

    COVID-19: Nearly 40% drop in STEMI cases in US cath labs since March 2020

    COVID-19: American Heart Association issue pandemic CPR guidelines

    COVID-19: Cotton and surgical masks may be ineffective at stopping spread of virus through coughs

    COVID-19: Both ACC and ESC urge patients to seek help if they experience symptoms of a myocardial infarction

    CE mark for transcatheter system that uses same clip technology as MitraClip

    US heart societies express concern over using hydroxychloroquine and azithromycin for COVID-19

    Philips and the US government collaborate in ventilator production ramp up to combat COVID-19 pandemic

    Mardil Medical completes treatment of third patient in VenTouch device trial

    Shockwave completes enrolment in study of coronary intravascular lithotripsy

    Webinar: Cardiovascular specialists detail COVID-19 strategies

    AHA issues oxygenation and ventilation guidance for healthcare providers

    Decreased ACE2 levels found in ageing and cardiovascular disease can increase likelihood of severe COVID-19

    COVID-19: Edwards pauses enrolment in mitral and tricuspid trials to allow hospitals to focus on virus

    COVID-19: European Commission agrees to postpone new MDR because of pandemic

    Athena Poppas begins ACC presidency

    PPE guidance for cardiology during COVID-19 pandemic operating in a “vacuum” in UK

    CMSS

    CMSS “strongly urges action” to ensure all frontline healthcare professionals are protected

    Raised troponin and interleukin-6 levels are associated with a poor prognosis in COVID-19

    Italy, USA and the UK share their cardiology COVID-19 experiences in LIVE Webinar

    Cardiologists share COVID-19 insights

    ACS defends healthcare workers as PPE shortages lead to acrimony

    Daniel M Philbin Jr named new chair of the ACC board of governors

    Live webinar on Thursday 2 April to share COVID-19 cardiovascular experience

    Virtual ACC: Edoxaban non-inferior to warfarin for preventing thromboembolism after surgical bioprosthetic valve replacement

    Virtual ACC: Mavacamten “promising” in treatment of non-obstructive hypertrophic cardiomyopathy

    Virtual ACC: PRECOMBAT finds PCI as good as CABG at 10 years in left main disease

    MitraClip in moderate surgical risk patients

    Virtual ACC: Newer generations of MitraClip associated with greater reduction in mitral regurgitation than previous version

    coronary artery bypass

    Virtual ACC: Use of radial artery in heart bypass surgery improves patient outcomes

    Onyx One Clear Study

    Virtual ACC: Medtronic shares positive results of Onyx ONE Clear Study

    Virtual ACC: Clopidogrel exposure along with aspirin and rivaroxaban should be “minimised or avoided” in PAD revascularisation

    Virtual ACC: High success rate for TAVI in bicuspid aortic stenosis patients

    Michael Bohm

    Virtual ACC: Renal denervation bests sham control to safely lower blood pressure in patients with untreated hypertension

    Virtual ACC: Largest left atrial appendage occlusion registry finds Watchman acute safety data “very encouraging”

    Virtual ACC: Antiplatelet drugs increase risk for TAVI patients with atrial fibrillation

    Virtual ACC: Low-dose colchicine after myocardial infarction is “economically dominant”

    Virtual ACC: Combining aspirin with rivaroxaban provides greater absolute risk reduction in diabetes

    Virtual ACC: Aspirin plus rivaroxaban significantly lowers adverse events in PAD revascularisation

    Virtual ACC: Genotype-guided therapy after PCI does not hit study target

    COVID-19: European Commission looking to postpone new MDR by one year

    Adapt clinical studies to alleviate effect of pandemic

    Cardiac injury in COVID-19 patients linked with higher death rate

    CDRH adjusts working practices with medical device companies to deal with COVID-19

    AHA commits US$2.5 million for fast-tracked COVID-19 heart and brain research

    BCIS and BCS ratify NHS guidance for cardiology during COVID-19 pandemic

    SCAI launches web section devoted to COVID-19 updates and cancels Scientific Sessions

    Duo device for tricuspid repair records first successful use in humans

    New guideline: ASA no longer recommended to prevent first stroke, heart disease

    One-third of critically ill COVID-19 patients in Washington State series developed cardiomyopathy

    FDA issues new policy on remote monitoring devices for use during COVID-19 pandemic

    First report gives insight on impact of COVID-19 in heart transplant patients

    ageing mitral valve surgery

    Frailty predicts greater death rate and higher costs after mitral valve surgery

    SCAI issues advice for cath labs in light of COVID-19 pandemic

    Transcatheter heart valves are overlapping with coronary arteries

    TriGUARD 3 given CE mark for embolic protection during TAVI

    Portola Pharmaceuticals unveils data on Andexxa in patients with multiple types of Factor Xa inhibitor-related bleeds

    Early quality of life increases or benefits in COAPT translate to better long-term clinical outcomes

    PCI for chronic total occlusion less successful after bypass surgery

    ACC.20/WCC will be a virtual meeting

    Long-term exercise may lead to aortic enlargement and remodelling

    Abbott receives CE mark for FlexNav delivery system

    New England Journal of Medicine to review EXCEL data

    Paclitaxel coated balloons have lower risk of mortality in coronary arteries at three years than control treatments

    CryoLife given CE mark for On-X Ascending Aortic Prosthesis

    FDA issues update on reducing the risk of patient infections during cardiac surgery

    First patients enrolled in PROACTIVE-HF trial of Cordella pulmonary artery pressure sensor system

    Heart Research UK awards grant to University of Leeds to develop new heart failure treatments

    CRT 2020: TAVI safe at 30 days in low-risk bicuspid aortic stenosis

    CRT 2020: Stage 3 kidney injury after TAVI leads to seven times higher mortality

    CRT 2020: Biotronik reports three-year results for Orsiro DES from BIOFLOW-V trial

    Append Medical share clinical proof-of-concept results for internal sealing of LAA

    Edwards Life sciences initiative

    Edwards expands its Every Heartbeat Matters initiative

    Self-expanding and balloon-expandable valves are equally effective in high-risk TAVI

    Ablative Solutions publishes data from the Peregrine post-market study

    Cardiovalve

    Cardiovalve receives Breakthrough Device Designation for its transcatheter tricuspid valve replacement system

    BBC Newsnight makes fresh claims about allegedly withheld mortality data in EXCEL

    VitalConnect adds arrhythmia detection to its remote monitoring software

    JIM 2020: Weigh up early and late events in EXCEL to determine treatment for left main disease

    AI-guided cardiac imaging system given FDA authorisation

    Orsiro Mission DES

    Orsiro Mission gets CE mark

    Philips iFR Coregistration SyncVision

    Philips announces DEFINE GPS study of PCI guided by integrated iFR and X-ray

    Germany renews Revivent’s NUB reimbursement status 1 for 2020

    CABG shows 10-year benefit over PCI in left main patients with high SYNTAX score

    Medtronic begins pilot study as part of SPYRAL HTN clinical programme for renal denervation in hypertension patients

    FDA Breakthrough Device Designation for fully implantable left ventricular assist system

    Portola Pharmaceuticals appoints Rajiv Patni as executive vice president and chief medical officer

    Guy’s and St Thomas’ to merge with Royal Brompton & Harefield NHS Foundation Trust

    Abbott becomes first company in world to have transcatheter mitral implantation device on market

    STS 2020: Harness the power of Twitter to give your research greater impact

    Biotronik

    Biotronik appoint company’s first chief medical officer

    STS 2020: Young patients with aortic valve disease do better with SAVR than TAVI

    STS 2020: Enhanced surgical recovery protocols will allow safe three-day discharge

    distal

    New randomised study investigating distal radial access, DISCO RADIAL, launches

    Low albumin, anaemia, and slow walking speed predict mortality after TAVI

    First patient enrolled in PREDICT-LAA clinical trial

    SAFEPASS 2 clinical study of the Emboliner embolic protection catheter

    Emboline completes enrolment in SAFEPASS 2 clinical trial

    BioCardia gets FDA clearance for catheter to guide Helix delivery system

    Davide Capodanno, Gilles Montalescot, Marco Valgimigli and Dirk Sibbing

    Spartan Bioscience sets up European advisory board for precision medicine test in cardiac stent patients

    EXCEL finds repeat revascularisations following both CABG and PCI lead to increased mortality

    STS says independent analysis of EXCEL is best opportunity to “get it right for patients”

    ACC makes senior staff appointments

    Abbott gets green light for trial on MitraClip in moderate surgical risk patients

    Self-expanding valves show good haemodynamic performance in small annuli

    remote monitoring

    FDA approves Abbott heart pump for less invasive surgical approach

    Jean-Claude Dubacher named chairman and CEO of B Braun Medical

    Proximo Medical to partner with CeloNova Biosciences

    EXCEL: EACTS reaches out to trial investigators to “resolve concerns”, as CRF commissions independent review

    EXCEL: EACTS explains its decision-making on left-main guidelines, and AATS calls for all data to be published

    Corresponding author Evald Hoj Christiansen

    NOBLE finds PCI inferior to CABG at five years in left main disease

    EACTS and STS announce strategic partnership

    FDA grants Breakthrough designation for ECG-based algorithm

    The results of the safety profile and efficacy of Lixiana study

    European trial data ‘reinforce’ safety profile and efficacy of Lixiana

    impella in preventing heart failure in stemi patients

    New trial to evaluate role of Impella in preventing heart failure in STEMI patients

    EXCEL leadership refute BBC Newsnight claims in 3,500-word document

    Routine anticoagulation with rivaroxaban after TAVI harmful: GALILEO trial results

    BBC Newsnight investigation of EXCEL prompts EACTS to reject 2018 European recommendations on left main disease

    InnovHeart appoints Brent Ratz as independent member of the board

    Bioventrix announces positive one-year outcomes for Revivent TC system

    Enrolment completed for MASTER DAPT trial

    AHA 2019: ISCHEMIA shows no benefit for revascularisation in patients with stable ischaemic heart disease

    AHA 2019: Preprocedural COLCHICINE-PCI finds a lowering of inflammation, but no reduction in myocardial injury

    PCR London Valves 2019: Meril unveils positive data for Myval

    Corindus completes first transcontinental simulated telerobotic PCI procedures over 5G, fibre, and public internet networks

    Revivent transcatheter system receives Breakthrough Device Designation from the FDA

    PCR London Valves 2019: PARTNER 2 analysis shows Sapien 3 valve as durable as surgical valves at four years

    PCR London Valves 2019: TRILUMINATE shows safety and efficacy of TriClip maintained at one year

    PCR London Valves 2019: A simple algorithm can reduce unnecessary pacemaker implantation after TAVI

    AHA 2019: Endotronix shares data from in-human trial of Cordella pulmonary artery pressure sensor

    PCR London Valves 2019: One-year survival better with Mitra Clip than with medical therapy among COAPT-excluded patients

    Shockwave commences IVL study to support regulatory approval in Japan

    “Cuffless” system to monitor blood pressure could replace traditional methods

    Multiphase and early systolic phase CT screening in TMVR superior to end systole analysis at predicting obstruction risk

    GLOBAL LEADERS: no sex-difference in mortality or MI rates two years after PCI, but bleeding risk higher in women than men

    Left atrial appendage closure associated with a decreased stroke risk in AF patients

    Pre-TAVI aortic regurgitation aids survival post-TAVI in mixed aortic valve disease patients

    US FDA grants Breakthrough Device designation to CorFlow Infusion System

    Cardionovum’s coronary DCB receives regulatory approval in China

    Corindus’ stockholders approve acquisition by Siemens Healthineers

    Two further studies support three-month DAPT following PCI

    Patients with angiographically-intermediate coronary lesions

    Diversity strategies in cardiology are not working, study finds

    patient deaths are under reported said Rita Redberg

    Device deaths are under reported, says research letter

    VEST external stent demonstrates low event and disease rates in two prospective trials

    Positive NICE recommendation for Xarelto to prevent atherothrombotic events in CAD and PAD patients

    Shockwave study demonstrates strong safety and procedural success of coronary IVL in Europe

    Admedus sells CardioCel and VacsuCel to focus on TAVI

    Penumbra announces enrolment of first patient in study of mechanical power aspiration for thrombus removal in coronary vessels

    Douglas Drachman named as next vice chair of American College of Cardiology’s Annual Scientific Session

    EACTS 2019: Leading cardiothoracic surgeon questions EXCEL trial’s conclusion

    Abiomed announces PROTECT III clinical data for protected PCI with Impella

    AccuCinch ventricular repair system associated with favourable safety profile at 30 days

    TCT 2019: Apixaban plus a P2Y12 inhibitor is the optimal strategy for AF with ACS and/or PCI

    CE mark granted to the Gore Cardioform ASD Occluder for the treatment of atrial septal defects

    Endotronix closes expanded series D financing round of US$70 million for Cordella

    TCT 2019: Resolute Onyx noninferior to BioFreedom in high bleeding risk patients treated with one-month DAPT

    TCT 2019: TAVI has sustained health status benefits over surgery for low-risk patients at one year, with similar five-year outcomes for intermediate-risk patients, unless via a transthoracic route

    TCT 2019: Benefits of complete revascularisation continue to accumulate over the long term

    TCT 2019: COAPT finds MitraClip safety and efficacy is maintained at three years, and is cost-effective

    TCT 2019: Acurate neo does not meet non-inferiority compared to Sapien 3

    TCT 2019: Safety and efficacy of Portico valve noninferior to FDA-approved TAVI systems

    TCT 2019: Aspirin withdrawal after three months of dual antiplatelet therapy reduces bleeding without an increase in ischaemic events among high-risk patients following PCI

    FDA approves Evolut PRO+

    Boston Scientific announces schedule of presentations at TCT 2019

    Corindus showcasing CorPath GRX system at TCT 2019

    Abbott starts trial to evaluate TriClip for percutaneous repair of tricuspid regurgitation

    merit-medical-radial-compression

    Merit Medical unveils PreludeSYNC EVO radial compression device

    ESC 2019: Registry study supports use of ICDs for primary prevention in patients with heart failure

    ESC 2019: Two-year findings of MITRA-FR continue to show no prognosis benefit with MitraClip

    ESC 2019: Ultrathin strut Orsiro better than thin strut Xience for STEMI patients

    ESC 2019: Left atrial appendage closure is non-inferior to NOACS for preventing major neurological, cardiovascular, and bleeding events

    complete-revascularisation

    ESC 2019: Complete revascularisation superior to culprit lesion-only PCI in STEMI and multivessel CAD irrespective of timing of intervention

    ESC 2019: Prasugrel bests ticagrelor for the management of acute coronary syndromes

    ESC 2019: Abiomed launches Impella SmartAssist platform

    Low-dose polypill could be used for primary prevention of cardiovascular events

    FARXIGA meets primary endpoint in Phase III DAPA-HF trial

    CeloNova appoints new president and CEO

    FDA approves new device to improve symptoms in patients with advanced heart failure

    FDA approves Sapien 3 Ultra, Sapien 3, and CoreValve for low-risk TAVI

    Announcing the TCT 2019 late-breaking trials and science

    wirion

    Cardiovascular Systems acquires Gardia Medical’s Wirion embolic protection system

    Transcatheter repair of tricuspid valves appears safe and effective when surgery is not an option

    Hormone therapy linked to heart fat and hard arteries

    SeQuent Please ReX drug-coated PTCA balloon catheter receives FDA breakthrough device designation

    xarelto rivaroxaban

    Rivaroxaban recommended by NICE for peripheral and coronary artery disease patients

    Age alone should not preclude TAVI in patients aged ≥90 years

    Unfilled prescriptions for PCSK9 inhibitors lead to higher rates of cardiovascular events

    Medtronic enters into AI partnership for stroke care

    TARGET BP I trial enrols its first patient

    Edwards Lifesciences to discontinue its self-expanding valve Centera

    Edwards Lifesciences issues urgent safety notice for Sapien 3 Ultra

    Fourth-generation MitraClip receives FDA approval

    Women with idiopathic intracranial hypertension at twice the risk of cardiovascular disease

    SAVR has lower mortality and MACCE than TAVI using first-generation devices in low- and intermediate-risk patients after five years

    Carillon Mitral Contour System reaches 1,000 implants for functional mitral regurgitation

    Medtronic announces global registry of HVAD thoracotomy implants

    FEops HEARTguide wins CSI Highlight of the Year Award

    Edwards Lifesciences issues an urgent field safety notice for Centera TAVI system

    MeRes100 BRS demonstrates sustained safety and efficacy

    Admedus’ announces favourable five-year outcomes for its CardioCel bioscaffold

    PASCAL poised to rival MitraClip for safety and efficacy

    NICE issues recommendations on insertion of cerebral protection devices during TAVI

    Zoll Medical acquires TherOx

    Patent granted to Valfix Medical for its percutaneous valve and replacement technology

    Robotic PCI company adds interventional cardiology experts to its medical advisory board

    Philips announces new advanced automation capabilities for its EPIQ CVx and EPIQ CVxi cardiac ultrasound systems

    India-designed Myval associated with no device-related mortality at one year

    Mentice and Siemens Healthineers aim to bring a virtual patient to the angio-suite

    Nearly 50% of treatment strategies would change with use of investigational HeartFlow planner

    DSM and SAT enter partnership to develop the first next-generation heart valve

    CMS’ update to coverage policy for TAVI provides greater flexibility for hospitals and providers

    New trial to compare Watchman FLX to direct oral anticoagulants

    US$170m funding for Acutus Medical

    SCAI document provides advice on cath labs’ financial viability

    TVT 2019: PASCAL system may be beneficial for managing tricuspid regurgitation

    TVT 2019: Purpose-designed temporary pacing guidewire has potential to make implantation of transcatheter heart valves “safer and more efficient”

    TVT 2019: TAVI is “preferred therapy” for low-risk patients

    Virtue sirolimus-eluting balloon set for commercial release as Terumo and Orchestra BioMed enter global strategic partnership

    Cardiologists can help to avert nuclear doomsday

    PCR statement on TAVI signals “paradigm shift” in treatment of severe symptomatic AS

    Early treatment with Helix system improves ejection fraction and symptoms

    Biotronik announces positive data for Magmaris

    FDA approves Cardioform ASD Occluder for the treatment of atrial septal defects

    American College of Cardiology names its first director of diversity and inclusion

    Philips launches IntraSight interventional applications platform

    Boston Scientific initiates trial comparing left atrial appendage closure to direct oral anticoagulants for stroke risk reduction post-AFib ablation

    Medtronic launches Telescope guide extension catheter

    EuroPCR 2019: VIVALL pilot study shows promise for safe use of Allegra heart valve in bioprostheses

    EuroPCR 2019; TRILUMINATE suggests TriClip is safe and effective

    EuroPCR 2019: PCR issues statement on edge-to-edge repair in heart failure management with secondary MR

    EuroPCR 2019: Renal denervation linked to reduction in subclinical atrial fibrillation

    EuroPCR 2019: Ultrathin stent demonstrates benefits in small vessels

    EuroPCR 2019: Consensus paper on intracoronary imaging focuses on acute coronary syndrome

    Diagnosing coronary stenosis with diastolic pressure ratio measurements is equivalent to using iFR

    ClearFlow announces positive trial results and inclusion in ERAS guideline recommendations for its PleuraFlow system

    Randal J Thomas looks to home-based cardiac rehabilitation

    USA needs to put greater emphasis on home-based cardiac rehabilitation

    Keith Dawkins appointed as chief medical officer at Shockwave Medical

    Avance steerable introducer given FDA 510(k) clearance

    Cordis expands its interventional cardiology portfolio with full US launch of radial products

    impella in preventing heart failure in stemi patients

    FDA approves extended duration of use for Impella 5.0 and Impella LD heart pumps

    Majority of cath labs feel burdens of PCI public reports outweigh benefits

    Less than half of vein graft interventions use embolic protection

    Triage STEMI patients for ICU after PCI based on reperfusion timing

    Vitros high-sensitivity troponin assay receives CE mark

    NeoChord raises additional financing to drive catheter‐based programme development

    Biotronik launches PK Papyrus covered coronary stent in the USA

    Virtue SEB given breakthrough device designation by FDA

    Bardy Diagnostics announces $35.5M funding injection

    Lotus Edge becomes third TAVI device on US market

    US FDA approve SSO2 Therapy for the management of myocardial infarction

    TAVI company Tioga Medical closes US$15M in series A financing

    PhaseBio receives FDA breakthrough therapy designation for PB2452 for the reversal of the antiplatelet activity of ticagrelor

    Targeted blood pressure management helps to reduce strokes in patients with HVAD

    CE mark for the FEops HEARTguide

    Comics may help patients to better understand coronary interventions

    Prevalence of multiple organ failure among cardiogenic shock patients has steadily increased

    ACC 2019: Less bleeding with one-month DAPT than standard therapy, with no increased ischaemia

    RADIANCE SOLO HTN finds greater blood pressure drop after renal denervation

    Alirocumab receives EC approval in established atherosclerotic cardiovascular disease

    Richard Kovacs assumes presidency of the American College of Cardiology

    ACC 2019: TAVI moves to the mainstream with new findings in low-risk patients

    CRT 2019: Evolut R superior to surgery at one year in intermediate-risk patients

    CRT 2019: Alert system is safe, quick, and has few complications

    MitraClip in moderate surgical risk patients

    MitraClip can be used to treat secondary mitral regurgitation in the USA

    Micro Interventional Devices enters strategic alliance with Oscor

    CardioCel 3D and VascuCel receive regulatory approval in Europe

    ACC to offer transcatheter valve certification to help hospitals implement best practices

    CE mark for Watchman FLX left atrial appendage closure device

    Scott Gottlieb resigns as head of US FDA

    CRT 2019: Peregrine catheter demonstrated 100% procedural success in post-market clinical trial

    CRT 2019: Early resorption and low complications demonstrated for Magmaris

    Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study

    Woman patient

    Myocardial infarction patients taken directly to heart centres have better long-term survival

    CRT 2019: Three-year data shows trend towards lower target vessel failure with Orsiro vs. Resolute Integrity and Synergy

    CRT 2019: US FDA approves resting full-cycle ratio for measuring severity of coronary artery blockages

    CX 2019 to host first-ever aortic and peripheral virtual reality live cases

    Polymer-free stents have similar performance profiles, except in diabetes

    Sapien 3 provides safe and satisfactory access via the transcarotid route

    MedAlliance granted “breakthrough device designation” from FDA for its sirolimus-coated balloon

    New Australian research and development partnership aims to innovate heart failure care

    American College of Cardiology to launch new journal dedicated to cardio-oncology

    Augmented reality surgical technology unveiled by Philips and Microsoft

    US physicians can now use Resolute to treat chronic total occlusions

    CE mark for R-One robotic-assisted solution for treating coronary diseases

    FDA approves Orsiro for use in the USA

    iVascular receives CE mark for Navitian microcatheter

    CE mark for PASCAL mitral valve repair system

    ACC to tackle patient, provider access to novel therapies

    Zenition

    Philips launches Zenition mobile C-arm platform

    Rehab programme after myocardial infarction helps to reduce death

    One in five US patients with atherosclerotic cardiovascular disease cannot pay their medical bills

    Long-term function of TAVI valves “is excellent”

    Leviticus Cardio and Jarvik Heart new fully implanted ventricular assist device

    London hospital provides first video consultation service for specialist care in England

    Less than a third of Americans known that cardiovascular disease is the biggest cause of death

    US FDA grant premarket approval to Manta vascular closure device

    First trial of in-heart micro device for left atrial pressure monitoring launched

    PreludeSync distal compression device now available globally

    Alvimedica announces CE mark for Cre8 Evo 2mm

    Registry data for Biotronik’s bioresorbable scaffold Magmaris supports its roll-out into clinical practice

    CE mark for cloud-based monitoring platform Impella Connect

    German NUB Status 1 designation for Neovasc Reducer renewed

    Editors-in-chief of major cardiovascular journals claim medical misinformation puts “lives at stake”

    The British Heart Foundation’s “Big Beat Challenge” is now accepting proposals

    SCAI

    Society for Cardiovascular Angiography and Interventions supports continued use of paclitaxel devices

    FDA IDE approval for safety and feasibility clinical trial of Cor Tricuspid ECM valve

    Vascular Dynamics names Martin Rothman chief medical officer

    Philips launces Azurion with FlexArm to aid image-guided procedures

    Positive results for LivaNova’s Perceval sutureless valve

    Abbott to acquire Cephea Valve Technologies

    shutdown

    US government shutdown disrupting FDA work

    Absence of known cardiovascular risk factors increases risk of sudden cardiac arrest in the setting of STEMI

    TAVI-induced bundle branch block and permanent pacemaker implantation are “not benign”

    New JACC publication reinforces valve of a coronary CTA + HeartFlow Analysis-guided pathway for diagnosing heart disease

    JenaValve Technology appoints John T Kilcoyne as chief executive officer

    Shockwave initiates US pivotal study for coronary intravascular lithotripsy

    Sleeping less than six hours a night may increase cardiovascular risk

    FDA approves world’s first device for treatment of premature babies and newborns with an opening in their hearts

    Boston Scientific, Edwards Lifesciences agree to global litigation settlement

    Does your insurance card matter when you have a heart attack?

    SCCT releases new guideline for use of computed tomography in TAVR procedure

    Patient recruitment reaches half-way point for global DAPT study

    First United States treatment with J-Valve TAVI device

    Increased BMI associated with significant increase in radiation exposure to physicians

    Meta-analysis shows FFR-guided PCI reduces myocardial infarction

    Unique therapeutic approach to treating uncontrolled hypertension receives US$77 million financing

    Sapien 3

    Sapien 3 Ultra receives FDA approval

    Internationally renowned cardiac surgeon joins University of Miami Health System

    FFRangio system receives US FDA clearance

    Boston Scientific exercises option to acquire Millipede

    First patients treated in United States with OrbusNeich Teleport Microcatheter

    More work needed to “untangle reasons” for gender gap in cardiovascular research

    The SYNTAX score should not be used to choose between CABG and PCI in diabetic patients with multivessel disease

    BioCardia submits 510(k) application to US FDA for its Avance steerable introducer for transseptal access to heart

    Merit releases Prelude IDeal hydrophilic sheath

    US District Court for the District of Delaware rules that Sapien 3 infringes a Boston Scientific patent

    Abiomed invests $15 million in Shockwave Medical

    Edwards Lifesciences to collaborate with Bay Labs to use AI software to improve detection of heart disease

    Woman patient

    Women wait for longer before calling for help when experiencing heart attack symptoms

    First-in-human “remote PCI” performed

    HeartFlow initiates PRECISE randomised clinical trial

    MitraClip in moderate surgical risk patients

    Draft NICE guidance supports use of percutaneous mitral valve repair

    paclitaxel

    Meta-analysis finds a higher risk of death in the long term when paclitaxel-coated devices are used in the leg

    Fantom bioresorbable scaffold implanted for the first time in Italy

    First implant of Pascal transcatheter mitral valve repair device performed in CLASP IID trial

    JenaValve receives FDA approval for expanded IDE enrolment in the treatment of patients with severe aortic stenosis and severe aortic regurgitation

    Personalised ultrasound scan showing atherosclerosis helps reduce cardiovascular risk

    Quidel receives CE mark for its TriageTrue high sensitivity troponin I test

    WeHealth by Servier and MobioSense form a partnership to develop digital portable myocardial infarction detection test

    American College of Cardiology New York Cardiovascular Symposium to bring together top cardiologists

    Presence of left bundle branch block significantly increases risk of pacemaker implantation after TAVI

    US FDA plan shakeup of its 510(k) clearance programme

    AHA 2018: Efficacy and safety of PCI with Ti-no coated bio-active stents presented

    Frail, older patients have 50% increased risk of bleeding during hospitalisation for myocardial infarction

    Sapien 3

    Launch of Sapien 3 Ultra hampered by Boston Scientific dispute

    Bay Labs and Northwestern Medicine enrol first patient in study using AI software to improve heart disease detection

    HeartFlow receives national reimbursement approval in Japan

    AHA 2018: Early invasive strategy without pretreatment significantly reduces recurrent ischaemic events in NSTE-ACS patients

    AHA 2018: Pilot study paves way for future evaluation of delaying reperfusion in STEMI patients

    US FDA approve new study of Medtronic’s Spyral renal denervation system

    Vivasure Medical announces launch of the PerQseal large bore closure device

    NeoChord announces US$25 Million Series D financing to accelerate development of two transcatheter chordal repair programmes

    AHA 2018: Study shows AliveCor phone app can effectively identify STEMI with nearly the same accuracy as a standard ECG

    First patient in Hong Kong receive treatment with coronary Orbital Atherectomy System

    Mark Schwartz become vice president of Clinical Affairs at BioCardia

    Cordis launches Mynx Control vascular closure device in the USA

    Fantom Encore launched onto market

    First US implantations of TriCinch Coil tricuspid valve repair system performed

    Colder air and reduced sunshine increases risk of myocardial infarction

    Atrial fibrillation related to PFO closure occurs early and is transient

    New drug formulation could help people undergoing heart surgery

    BioCardia and CellProThera to partner for clinical trial and marketing in Singapore of early stem cell therapy

    TCT 2018: Durable tricuspid regurgitation reduction with MitraClip

    TCT 2018: Severe prosthesis-patient mismatch linked to increased mortality at one year

    iVascular acquires 10% of NaviGate Cardiac Structures for US$10 million

    US FDA approve HeartMate 3 heart pump for advanced heart failure patients not eligible for a heart transplant

    Single-use, high-definition, miniature camera unveiled at Asia Pacific MedTech Forum 2018

    First patient enrolled in STTAR study of MIA—minimally invasive annuloplasty

    Caristo Diagnostics launched to commercialise new coronary CT image analysis technology

    Rivaroxaban gets FDA approval for treatment in CAD or PAD

    TMVI with Tiara valve may be safe and feasible for patients with prior aortic valve replacement

    Risk of death with unrecognised myocardial infarction equal to that with recognised myocardial infarction by 10 years

    FDA approve TSP Crosser transseptal access system

    Teleflex buys vascular closure company Essential Medical

    US trial of Edwards’ self-expanding Centera valve begins

    Only one third of patients in China receive cardiac rehabilitation

    TCT 2018: IVUS-guided PCI reduces target vessel failure in all-comers population

    Heart Research UK award £250,000 to researchers developing AI test for coronary heart disease

    Venus Medtech to buy cerebral protection device company Keystone Heart

    Megha Prasad selected as SCAI-Women in Innovations CHIP Fellowship

    TCT 2018: Orsiro continues to have lower rates of target lesion failure than Xience

    TCT 2018: One-year real-world results show Portico TAVI system reduces severe aortic stenosis

    TCT 2018: Longest-term data to date for CoreValve study show excellent valve durability out to five years

    TCT 2018: Use of Impella in cardiogenic shock patients associated with relative 24% increase in survival

    TCT 2018: LEADERS FREE II confirm favourable results for BioFreedom

    TCT 2018: Restore drug-coated balloon matches Resolute for small vessel lesions

    TCT 2018: FFRangio may provide a faster and easier approach to physiological assessment

    TCT 2018: Audience claps as COAPT shows MitraClip reduces HF hospitalisations

    TCT 2018: Lower rate of stent thrombosis with Resolute Onyx vs. Orsiro

    US FDA approve study of CoreValve Evolut in low-risk patients with bicuspid valves

    First patient enrolled in CARILLON pivotal trial

    PCR LV 2018: One-year results of VIVA confirm safety and efficacy of valve-in-valve procedures with CoreValve

    PCR LV 2018: Early discharge feasible for unselected TAVI patients

    PCR LV 2018: Favourable outcomes for next-generation Acurate neo2 TAVI system

    Onyx One Clear study starts in USA and Japan

    US FDA approves PK Papyrus stent for coronary perforations

    Two patients have been implanted with latest-generation of integrated ICE delivery system

    TCT 2018: Infraredx to present results of the LRP study

    TCT 2018: Corindus to feature the CorPath GRX system at conference

    SCAI mourns past president Joseph D Babb

    BTG buys Novate Medical

    Gore buys transcatheter mitral chordal repair technology

    First patients enrolled in trial of MobiusHD for drug-resistant hypertension

    ESC 2018: TMVI associated with “excellent outcomes” for valve-in-valve procedures

    SIS Medical to launch three innovative balloon catheters

    ESC 2018: More evidence that FFRCT is an effective approach for identifying patients who do not require further intervention

    Patients with new-onset atrial fibrillation after TAVI have highest risk of complications

    ESC 2018: First US FDA-approved study shows TAVI is safe for low-risk patients

    ESC 2018: Novel imaging biomarker can predict risk of cardiac mortality

    ESC 2018: Positive one-year results for Interatrial Shunt Device

    ESC 2018: All-cause mortality in cardiogenic shock multivessel PCI only increased during first 30 days

    ESC 2018: Ticagrelor monotherapy approach does not challenge current DAPT approach

    ESC 2018: No difference in MACE between drug-coated balloons and drug-eluting stents for de novo lesions in small vessels

    ESC 2018: Higher all-cause mortality with Orsiro at five years than with Xience

    ESC 2018: MitraClip makes “absolutely no difference” for the prognosis of secondary mitral valve regurgitation

    ESC 2018: Greater use of PCI for high SYNTAX score patients may explain higher rate of all-cause death with FFR in FUTURE

    Simultaneous TAVI and left atrial appendage closure is feasible

    ESC 2018: Non-atherosclerotic spontaneous coronary artery dissection predominantly affects young to middle-aged women

    ESC 2018: British Heart Foundation to provide £30m for innovation in heart disease

    Cerner and Duke Clinical Research Institute collaborate on new app for calculating cardiac risk

    ESC 2018: Siemens Healthineers showcase Magnetom Sola Cardiovascular Edition

    ESC 2018: Cardioskin launched

    Bayer announces new licensed indication for use of Xarelto in patients with coronary artery disease

    Twenty thousand patients have now been treated with RenalGuard therapy

    More than 100,000 people now know hands-only CPR thanks to AHA programme

    ClearFlow awarded group purchasing agreement for the chest drainage products category with Premier

    Philips launches new cardiac ultrasound solutions with anatomical intelligence

    Novel Ultraseal device is a feasible option for left atrial appendage closure

    Three-quarters of patients have sustained results at very long-term follow-up after percutaneous balloon mitral valve valvuloplasty

    “No option” for revascularisation in refractory angina does not mean never

    FDA sends letter warning about mortality and risks with the Syncardia TAH-t Companion 2 Driver

    Enrolment in FAST-FFR trial completed early

    Chronic kidney disease should not be a barrier to TAVI

    Re-evaluate use of anticoagulation in patients with atrial flutter

    Female acute myocardial infarction patients experience worse outcomes when treated by male physicians

    Patient enrolment in US early feasibility study of Everdur TAVI device initiated

    PRECLUDE study of Caisson TMVI system concludes

    Safety and efficacy results of REDUCE study published in International Journal of Cardiology

    Boston Scientific closes acquisition of Claret Medical

    New research links even low levels of air pollution with serious changes in the heart

    VisONE system for heart failure implanted for first time

    CE mark and US FDA approval for RadialSeal introducer kit

    Infraredx launches Makoto intravascular imaging system and Dualpro IVUS+NIRS catheter in Japan

    US FDA approval for SynchroMed II implantable system for treating pulmonary arterial hypertension

    Bayer receives positive CHMP opinion for rivaroxaban for patients with coronary artery disease

    On the fence result for initial CMS vote about TAVI volume requirements

    Abbott launches trial of its Tendyne transcatheter mitral valve implantation device

    Siemens Healthineers transforms care delivery with innovative new tests for faster diagnosis of myocardial infarction

    Benefit of epinephrine in out-of-hospital cardiac arrest countered by its neurologic effects

    Nitroglycerin may be a safe, effective, and economic approach of reducing risk of radial arterial occlusion

    “Remote PCI” successfully performed 100 miles away from the cath lab

    Advance CS coronary sinus infusion catheter used for the first time

    Boston Scientific to buy cerebral protection system company

    Reva’s Fantom scaffold is now being distributed in Italy

    Cardiovascular Systems signs international distribution agreement with OrbusNeich

    Societies launch joint report on TAVI

    Creavo launches largest US study of its kind

    US FDA clearance for TEECAD system for aiding transoesophageal echocardiography

    MitraClip in moderate surgical risk patients

    Next-generation of MitraClip approved for use in the USA

    Consider the transaortic approach when faced with difficult iliofemoral anatomy

    Malnourished patients have a three-fold risk of mortality after aortic valve replacement

    Funding for Neptune left ventricular assist device

    CPT code for CathWorks’ 3D FFRangio wire free system

    Otsuka Medical Devices, Otsuak Holdings, and ReCor Medical to merge

    New way to regenerate hearts after myocardial infarction identified

    HeartWare HVAD system receives US FDA approval

    First-in-human implant of BeGrow stent performed in 24-day old baby

    Leaflet thrombosis is not a predictor of stroke or all-cause mortality in the medium term

    Corwave announces issuance of US Patent Covering its implantable left ventricular assist device leveraging the wave membrane technology

    Cardiac hybrid imaging is an effective tool for predicting myocardial infarction

    FDA approves RADIANCE-II study of Paradise ultrasound denervation system

    Endotronix joins AHA’s Center for Health Technology & Innovation to broaden the use of guideline-based care for heart failure patients

    Lexington Biosciences concludes initial HeartSentry clinical study

    PERT Consortium and BTG form strategic partnership

    Largest insurer in USA now covers HeartFlow Analysis

    AorTech sign development agreement with Vascular Flow Technologies

    ACC’s ACTION registry to become Chest Pain—MI Registry

    TVT 2018: Tiara TMVI device featured in live case

    Novel “smart stent” can tell physicians when restenosis is occurring

    Carotid disease is not a risk factor for stroke or death in TAVI patients

    TVT 2018: Positive results for Manta large bore closure device

    One in five UK doctors say under staffing has affected patient safety

    Implantation of JenaValve successful in initial patients enrolled in CE mark study

    Bisexual men have more risk factors for cardiovascular disease

    Physicians are more willing to tolerate uncertainty about coronary artery disease testing if risk of malpractice is less

    Advantage of guided de-escalation of dual antiplatelet therapy seen in younger patients

    First patient enrolled in phase II of REFLECT study of TriGuard 3

    US FDA approve EchoMD AutoEF software for calculating left ventricular ejection fraction

    Caladrius receives FDA regenerative medicine advanced therapy designation for its CD34+ Cell therapy for refractory angina

    EuroPCR 2018: Study indicates “almost perfect agreement” between CT angiography and conventional angiography for revascularisation decisions

    EuroPCR 2018: Both immediate and delayed approaches seem to work for transient STEMI patients

    Combination of high-sensitive C-reactive protein with logistic EuroSCORE improves risk stratification in TAVI patients

    Consider patients’ risk of ischaemic stroke when choosing antiplatelet therapies after PCI

    EuroPCR 2018: Low incidence of cardiovascular mortality with Centera self-expanding valve at one year

    Corindus receives Japanese PMDA approval for its CorPath GRX system

    EuroPCR 2018: No significant difference in bioprosthetic valve dysfunction between surgical and TAVI devices at six years

    Europe braces for harder times in medical device innovation while US FDA eases regulations

    EuroPCR 2018: Real-world data confirm trial outcomes for Sapien 3

    EuroPCR 2018: FFR-guided PCI reduces spontaneous myocardial infarction

    Looks do matter—patients claim what doctors wear is important

    BCS 2018: Novel blood test for myocardial infarction could be used in portable device

    Biomerics acquires FutureMatrix Interventional

    US FDA classifies HeartWare HVAD power issues as a Class I recall

    EuroPCR 2018: New ORBITA analysis finds iFR/FFR values do not predict impact of PCI on exercise time

    EuroPCR 2018: Data confirms long-term safety and efficacy of Angiolite drug-eluting stent

    EuroPCR 2018: PiCSO therapy reduces infarct size in acute myocardial infarction patients

    The European Commission authorise use of evolocumab to reduce risk of myocardial infarction in patients with established cardiovascular disease

    EuroPCR 2018: Interim nine-month results for Magnitude presented

    Positive clinical results from eCOBRA study

    EuroPCR 2018: One- to two-year landmark analysis shows significantly lower target lesion failure with Orsiro vs. Resolute Integrity

    EuroPCR 2018: Strong early vessel healing with Resolute Onyx in one-month DAPT study

    EuroPCR 2018: DIAB8 randomised study to compare Cre8 Evo with everolimus-eluting stents in diabetic patients

    Xience Sierra approved for use in USA

    EuroPCR 2018: Further evidence for safety and efficacy of Magmaris bioresorbable scaffold

    EuroPCR 2018: Positive data for renal denervation reignites interest in field

    EuroPCR 2018: Two studies provide support for HeartFlow Analysis

    Intravascular Lithotripsy for coronary artery disease launched in Europe

    “Excellent valvular function” with NaviGate’s GATE tricuspid valved stent at one year

    Enrolment of US early feasibility study of AccuCinch system for left ventricular repair expanded

    EuroPCR 2018: Boston Scientific outlines its key presentations

    First patient treated in first-in-man study of ChordArt mitral valve repair system

    Use of Resolute Onyx to be explored for the treatment of bifurcation lesions

    EuroPCR 2018: First-in-human study of Leaflex Performer for aortic stenosis initiated

    Signal that left radial access reduces the risk of PCI-related stroke

    CoreValve shows “favourable performance” at long-term follow-up

    Cardiac Dimensions appoints Matthew Stark as vice president of Clinical and Regulatory Affairs

    Japan’s Ministry of Health Labour and Welfare grants national reimbursement for Xience Sierra

    Only 16% of patients participate in a formal exercise programme after cardiac hospitalisation

    Cardioband becomes first-ever transcatheter tricuspid system to receive the CE mark

    SCAI 2018: David A Cox becomes Society’s new president

    Non-emergent, uncomplicated target lesion revascularisation significantly increases mortality

    TMVI in inoperable patients is feasible but mortality high at one year

    Terumo receives CE mark for Ultimaster Tansei drug-eluting stent

    TAVI is increasingly seen as the preferred approach for aortic valve replacement in CABG patients

    Boston Scientific successfully opposes Edwards Lifesciences Corporation’s European patent EP 2,399,550 (550)

    CE mark for HeartStitch’s transapical access and closure device

    Medtronic appoints Laura Mauri as vice president, Global Clinical Research & Analytics

    Women are still less likely to receive high-intensity statin therapy after myocardial infarction

    Location of tricuspid regurgitation predicts procedural success of percutaneous edge-to-edge repair

    A third of patients do not disclose their use of complementary therapy to physicians

    GUIDE-HF trial to evaluate whether CardioMEMS can improve survival and quality of life for people with NYHA Class II–IV heart failure

    Abiomed receives FDA approval for Impella CP with SmartAssist and Optical Sensor

    US FDA approves Cardioform septal occluder for PFO closure to prevent recurrent ischaemic stroke

    New trial of Symplicity Spyral approved

    Study of next-generation JenaValve device completes enrolment

    CIT 2018: BIOFLOW-VI confirms non-inferiority of Orsiro to Xience

    Enrolment complete in CT imaging substudy of leaflet mobility with Sapien 3 in low-risk patients

    First two patients enrolled in early feasibility study of second-generation Colibri valve

    UK Court of Appeal dismisses Edwards Lifesciences’ appeal against Sapien 3 infringement ruling

    Rome hospital to participate in European DuraGraft registry

    More non-cardiac death explains higher rate of post-PCI mortality in females

    Evidence of substance abuse found in 10% of young myocardial infarction patients

    ACC 2018: Short-term DAPT after PCI in acute coronary syndrome patients is not safe

    ACC 2018: Morphologic characteristics may determine benefit of percutaneous PFO closure

    Enrolment complete in BIOSTEMI study

    ACC 2018: Using iFR over FFR saves US$896 per patient per year

    ACC 2018: Five-year data for CoreValve show strong haemodynamic performance

    FDA approves the world’s smallest mechanical heart valve

    Woman patient

    ACC 2018: Four-step protocol improves outcomes in STEMI patients and eliminates gender disparities

    ACC 2018: Alirocumab reduces cardiovascular events in high-risk patients

    ACC 2018: C Michael Valentine become new president of the American College of Cardiology

    Sapphire II PRO becomes US’s first and only 1mm coronary balloon

    HeartFlow enters into licensing agreement with Cedars-Sinai for AutoPlaque technology

    Cardiogenic shock patients would benefit the most from reducing contact-to-balloon time

    “Favourable” in-hospital outcomes for younger patients undergoing TAVI

    Myocardial infarction patients may benefit from having anxiety

    CE mark for 2.5mm Fantom Encore bioresorbable scaffold

    New “Corrie” app may reduce readmissions after myocardial infarction

    Following FDA approval, Resolute Onyx 2mm becomes smallest stent on US market

    FDA releases final rule on acceptance of data from clinical investigations for medical devices

    Edwards’ self-expanding Centera TAVI valve now on European market

    Short-term DAPT is feasible for patients undergoing percutaneous LAA closure

    Fifty US centres are now using Claret Medical’s Sentinel cerebral protection system

    Abiomed receives expanded FDA approve for high-risk PCI procedures

    First patient enrolled in trial reviewing 28-day DAPT with Xience

    LivaNova to buy TandemLife

    Patient enrolment at UK sites of European DuraGraft registry initiated

    American College of Cardiology expand programme to lower readmission rates after myocardial infarction

    Ticagrelor significantly reduces the risk of MACE in myocardial infraction patients with multivessel disease

    BioVentrix now has 2018 NUB Reimbursement Status 1 in Germany for its Revivent TC system

    ISET 2018: OPTALYSE PE trial reinforces safety and efficacy of EKOS therapy

    Stress response may be reason for link between traffic noise and cardiovascular disease

    Siemens Healthineers and Circle Cardiovascular Imaging announce joint development plan for MRI application products

    More than 185 million patients now have access to HeartFlow FFRct

    Depression significantly increases mortality after aortic valve replacement

    Laboratory-confirmed influenza significantly increases the risk of acute myocardial infarction

    Key interventional cardiologists come together to form medical advisory board for robotics company

    US FDA grants BioCardia IDE approval for the CardiAMP chronic myocardial ischaemia trial

    First patient enrolled in Tryton post-approval study

    Corindus Vascular Robotic to co-sponsor courses on transradial coronary interventions

    Telemark microcatheter receives US FDA approval

    Woman patient

    Patients who have an in-hospital cardiac arrest at the weekend continue to have worse outcomes

    Boston Scientific enters into an acquisition option agreement with Millipede

    Japanese Ministry of Health approve Biotronik’s Orsiro drug-eluting stent

    Prediabetes significantly increases risk of events after PCI

    Next-day discharge appears safe for TAVI patients without in-hospital complications

    Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised in six months

    First US commercial implants of Elunir drug-eluting stent performed

    Mayo Clinic using robot-assisted PCI for preclinical study on “telestenting”

    First patient enrolled in OPTIMIZE study of Svelte drug-eluting stent integrated delivery system and rapid exchange platforms

    Second myocardial infarction twice as likely to occur non-culprit artery than in culprit artery

    First-in-human implantation of the Cordella pulmonary artery pressure sensor performed

    Acarix announces start of multicentre trial for handheld CADScor system

    Sixty-day follow-up for the MANTA US pivotal trial completed

    Miracor Medical raises €25M to support clinical and prepare commercial activities

    Recommendations for the use of embolic protection devices during saphenous vein graft intervention may need revising

    Modifying procedural technique during TAVI may lower radiation exposure to patients

    Promising results for RenalGuard in heart failure patients

    London’s Science Museum honours 50 years of heart transplants

    Health Care Service Corporation deem that FFRCT may be a “medically necessary” procedure for guiding coronary interventions

    Janssen seeks approval for rivaroxaban to be used to reduce cardiac events

    Apple and Stanford Medicine launch app-based arrhythmia study

    M Lewis Kinard appointed as executive vice president, general counsel and assistant corporate secretary of the AHA

    Philips acquires cloud-based population health management solution provider VitalHealth

    Edwards Lifesciences acquires Harpoon Medical

    Harpoon Medical acquired by Edwards

    ICI 2017: Novel transcatheter mitral valve wins Best Technology Parade Presentation

    Pollution may derail benefits of walking in older adults

    Global survey indicates that patients with type 2 diabetes underestimate their risk of cardiovascular disease

    “Vast majority” of young myocardial infarction patients do not meet criteria for statin therapy prior to event

    STEMI patients at highest risk are less likely to receive optimal medical therapy

    EpicHeart soft-robotic heart assist device wins innovation award

    TCT 2017: FAME 2 provides support for PCI in stable disease after ORBITA

    Evolocumab becomes first PCSK9 inhibitor to be approved for use in the USA to prevent myocardial infarction

    TCT 2017: Advances in device technology needed to improve outcomes with Absorb

    Report calls for US to prioritise health resources towards diagnosing and diseases like cardiovascular disease

    Elunir drug-eluting stent approved for use in the USA

    Inhaled Xenon plus hypothermia may reduce myocardial injury after an out-of-hospital-cardiac arrest

    China’s first human implantation of a retrievable TAVI device successfully completed

    Boston Scientific pushes back plans for commercialisation of Lotus Edge TAVI device

    US patients have had more preventive care for cardiovascular disease under the Affordable Care Act

    AHA 2017: Widely used approach for preventing renal complications after angiography does not provide benefit

    AHA 2017: Novel transcatheter therapy for heart failure shows promise in sham-controlled trial

    Creavo's Vitalscan

    Creavo wins two awards for its cardiac imaging device

    AHA 2017: Nutty eating habits may lower the risk of cardiovascular disease

    AHA 2017: First patients enrolled in trial of IASD system for heart failure

    Precommercialisation of Serpentis drug-eluting stent announced

    New study shows significant clinical workflow and staff experience benefits of Azurion image-guided therapy platform

    AHA 2017: Fun in the bedroom is unlikely to cause a sudden cardiac arrest

    Neovasc receive approval to initiate COSIRA-II IDE clinical trial

    TCT 2017: Sham-controlled trial raises doubts about benefit of angiography-guided PCI for stable angina

    TCT 2017: Study challenges recommendations on the management of cardiogenic shock

    MitraClip becomes first approved device for transcatheter mitral valve repair in Japan

    Centers for Medicare and Medicaid Services finalise a new technology ambulatory payment classification for HeartFlow

    TCT 2017: Elixir reveals new drug-eluting stent

    TCT 2017: Pooled analysis of Magmaris studies continue to show no instances of scaffold thrombosis at 12 months

    TCT 2017: Next-generation FFR system launched

    TCT 2017: No advantage with extending dual antiplatelet therapy beyond six months in STEMI patients

    TCT 2017: Fantom bioresorbable scaffold continues to show positive outcomes at two years

    TCT 2017: Two studies support feasibility of transcatheter mitral valve implantation

    TCT 2017: No role for bare metal stents to reduce duration of dual antiplatelet therapy in older patients

    Sapien 3

    TCT 2017: TAVI “should be the preferred strategy” for patients at intermediate-risk

    TCT 2017: New data for CoreValve Evolut further support its use in intermediate-risk patients  

    TCT 2017: Combo dual-therapy stent is non-inferior to Xience at one year

    Xience Sierra is now on European market

    TCT 2017: Data for novel cardiac imaging technology unveiled

    TCT 2017: AI-driven cardiac ultrasound company to give two presentations

    Woman patient

    First year after a myocardial infarction poses more risks for women

    US FDA 510(k) clearance for its Nova Cross Extreme and Nova Cross BTK Micro catheter for support of guidewire access to discrete regions of the coronary and peripheral vasculature

    Cobra PzF nano-coated stent now being studied with 14-day DAPT in patients at high risk of bleeding

    Heart valve replacement surgery may not be a morning procedure

    Controlling blood pressure may help to prevent mitral regurgitation

    TCT 2017: Boston Scientific reveals presentations at conference

    Claret Medical closes on series C financing of US$14.5m

    First patient implanted with Intrepid TMVI device in APOLLO trial

    Second successful implant of minimally invasive annuloplasty system announced

    Myocardial infarction survivors more likely to use “emotion-focused” strategies to cope with stress

    “Neurocardiologists” could treat acute ischaemic stroke patients when a neurointerventionalist is not available

    Fantom bioresorbable scaffold implanted for first time in Switzerland

    TCT 2017: Elixir Medical to reveal “a game-changing metallic drug-eluting stent platform”

    Cardiology societies come together to provide new assessment options for subspecialities

    Coronary angiography after TAVI with a self-expanding valve is challenging but feasible

    Creavo Medical Technologies receives US FDA 510(k) approval for Vitalscan

    Relatively few chronic kidney disease patients require dialysis after TAVI

    US doctors urged to take action on gun violence

    First patient enrolled in Frontier IV clinical trial of PerQseal large arteriotomy closure technology

    TCT 2017: Alec Vahanian to receive the Master Clinical Operator award

    Study demonstrates feasibility and safety of RenalGuard of reducing risk of acute kidney injury in CABG patients

    CADScor system shown at the German Heart Days meeting

    Analysis of LAA closure devices reveals post-approval spike in safety events

    Pamela B Morris to be next American College of Cardiology scientific session vice chair

    Enrolment in BIOVITESSE trial of polymer-free coronary stent initiated

    Data for NobleStitch EL suture based closure system presented at CSI UCSF Congress

    Thomas F Lüscher becomes director of education, research and development at Royal Brompton & Harefield NHS Foundation Trust

    EACTS 2017: Vascular Graft Solutions to hold symposium on venous external support

    No significant differences in post TAVI outcomes between African Americans and Caucasians

    First patient enrolled in US arm of ALIVE pivotal clinical trial

    Essential Medical completes enrolment in US IDE trial of Manta

    First procedure performed in Rox Medical’s CONTROL HTN-2 clinical trial

    Missing out on breakfast may increase risk of atherosclerosis

    Sirolimus-coated balloon “may represent a new approach to treating in-stent restenosis”

    Woman patient

    Delayed diagnosis affects women’s treatment for heart disease

    BioCardia CardiAMP

    BioCardia phase III CardiAMP trial passes interim safety analysis

    Medtronic HeartWare HVAD approved for destination therapy

    Enrolment completed in US pivotal clinical study of Cardioform ASD Occluder

    PCR LV 2017: Refining implantation technique and device iterations may improve pacemaker rate seen with Lotus

    TherOx' SSO2

    US FDA accepts PMA application for TherOx’ SSO2

    US FDA approves coronary indication for ReFlow’s Wingman

    Spectranetics' Bridge

    FDA issues class I recall for Spectranetics’ Bridge occlusion balloon catheter

    Philippe Généreux appointed chief medical officer of Saranas

    New performance and quality measures for treating heart attack patients

    Optiflow arterial cannulae family launched onto the USA

    iVascular’s drug-eluting stent and drug-eluting balloon now available for sale in India

    American College of Cardiology says that reforms to US healthcare come at “expense of bipartisan negotiations”

    FORWARD PRO clinical study to evaluate longer term performance of CoreValve Evolut Pro

    FDA grants Abiomed pre-market approval for is Impella RP for right heart failure

    Direct stenting with drug-eluting stents may be associated with better outcomes

    Three studies support efficacy of PFO closure for reducing risk of recurrent stroke

    Cancer history influences treatment of myocardial infarction

    Creavo's Vitalscan

    Creavo’s Vitalscan “rule out” technology on show at EUSEM

    Toddler

    Re-interventions common in long-term Fontan procedure survivors

    Average age and income of US cardiologists on the rise

    CardiAMP Heart Failure trial to further evaluate use of regenerative therapy in heart failure patients

    Carag completes CE marking for its breakthrough Carag bioresorbable septal occluder

    FDA grants 510(k) clearance to Fysicon’s QMAPP haemodynamic monitoring system

    All-comers data indicate stroke-free survival is improved with Sentinel embolic protection device

    New meta-analysis finds RenalGuard reduces all-cause mortality in patients undergoing cardiac interventions

    Edwards Lifesciences’ Alterra adaptive prestent device used for first time to treat a malformed pulmonary valve

    TCT 2017: Cardiovascular Research Foundation announces late-breaking trials and first-report investigations

    Neovasc provides Tiara clinical update

    First patient enrolled in PRECISION GRX registry

    New literature review highlights that Perceval sutureless aortic valve is safe

    Court of Dusseldorf grants Alvimedica an injunction against A B Handels GmBH

    ESC 2017: Post-TAVI clinical leaflet thrombosis is “infrequently reported” but is a serious adverse event

    ESC 2017: More evidence that supplemental oxygen in normoxic patients with suspected myocardial infarction does not provide benefit

    “Low commercial sales” prompt Abbott to pull the plug on selling Absorb

    Minimally invasive annuloplasty has been used to successfully perform bicuspidisation of a tricuspid valve

    ESC 2017: CABG is the “preferred strategy” for multivessel revascularisation in patients with type 1 diabetes

    ProtEmbo cerebral protection system used for first time

    American societies come together to publish appropriate use criteria for valvular heart disease

    Abbott’s Full MagLev HeartMate 3 LVAD receives FDA approval

    ESC 2017: MobiusHD implant shown to reduce resistant hypertension

    A 52mm tricuspid valve successfully implanted into a transplanted heart

    ESC 2017: Rivaroxaban significantly lowers risk of stroke, cardiovascular death, and myocardial infarction in patients with coronary artery disease

    Global agreement between Philips and HeartFlow announced

    ESC 2017: Subanalysis of PEGASUS shows ticagrelor reduces cardiovascular death by 29% in patients with prior myocardial infarction

    US trial to evaluate safety and efficacy of Amplatzer for patent ductus arteriosus

    ESC 2017: Hexacath’s titanium-nitride-oxide coated stent matches Boston Scientific’s Synergy for acute coronary syndrome

    ESC 2017: Best-practice PCI outperforms conventional PCI in patients with de novo three-vessel disease

    ESC 2017: SPYRAL HTN-OFF MED provides “proof of principle” that renal denervation works

    ESC 2017: Significantly lower event rates with Orsiro than with Xience

    ESC 2017: Case builds for dropping aspirin from triple therapy in atrial fibrillation patients post PCI

    US FDA clears Biostable’s HAART 200 bicuspid aortic valve repair annuloplasty device

    “Singheart” offers step towards heart regeneration

    Woman patient

    Heart failure patient and clinician risk perceptions differ drastically

    Medtronic to undertake global randomised clinical trial of one-month DAPT in Resolute Onyx patients

    HeartFlow FFRct Analysis receives four Blue Cross Shield endorsements

    Marijuana use associated with three-fold risk of death from hypertension

    LivaNova’s Perceval sutureless valve awarded Centers for Medicare and Medicaid add-on payment

    Social inequality may impact adult cardiovascular risk before birth

    Novel mitral regurgitation therapy featured in Innovation Summit at Cardiovascular Innovations

    Medtronic’s Avalus pericardial valve receives CE mark and FDA approval

    SHS invests in heart valve-repair start-up CoreMedic

    Pneumonia or sepsis increases risk of cardiovascular disease in first year by six fold

    Absorb prompts Boston Scientific to rethink its bioresorbable scaffold programme

    Keystone Heart accelerate trials for third-generation of its TriGuard device

    CE mark for CoreValve Evolut Pro

    Merit Medical partners with world-renown interventional cardiologist to deliver transradial course

    2 Heart Research UK funds UCL research to improve baby congenital heart disease diagnosis

    New study to evaluate safety of three-month DAPT with Xience in high bleeding risk patients

    American College of Cardiology says it opposes US healthcare reform

    Roxwood Medical announces agreement with Abbott for distribution of products in USA

    French doctors revise emergency plans to better deal with terrorism

    New PET-CT scan improves detection of sarcoidosis secondary to cardiac

    Millipede 50mm annuloplasty ring used in first cases

    European Medicines Agency issues positive opinion for rivaroxaban

    4C Medical receives over US$8 million financing for transcatheter mitral regurgitation treatment

    Black people do not have a higher rate of mortality one year after PCI

    Orodispersible tablets of ticagrelor now available in the UK

    Health Canada approves a high-dose bolus regimen of tirofiban

    Philips adds to list of recent acquisitions by buying TomTec

    Some plant-based diets associated with higher risk of heart disease

    Embolic protection device company raises US$5million in series B financing for advanced device development and initiation of US clinical activities

    First myocardial infarction more likely to be fatal in black people

    Cardiovascular drugs behind almost a quarter of medication error-related serious medical outcomes

    Meta-Analysis compares the safety and efficacy of S-DAPT and L-DAPT at two years

    GE Healthcare and HeartFlow announce global collaboration

    Sildenafil-coated stent may help prevent blood clots and restenosis

    Radical changes required to ensure US women receive optimal healthcare

    CoreValve Evolut can be used to treat intermediate-risk patients in the USA

    Essential Frailty Toolset may be best assessment of frailty for aortic stenosis patients

    Medtronic releases Resolute Onyx drug-eluting stent in Japan

    AMA issues unique Category III Current Procedural Terminology codes for HeartFlow FFRct

    FDA approve “first-in-class” resilient surgical valve

    First German order for Acarix’ CADScore system

    Unique 3D-printed heart valves could reduce TAVI paravalvular leakage rates

    Shingles associated with stroke and heart attack

    NHS hospital failed to comply with UK law when it gave data to Google DeepMind

    CSI 2017: Global postmarket surveillance study to explore use of LAmbre LAA closure system

    Europace 2017: Breast implants may lead to false heart attack diagnosis

    Obamacare health insurance expansion linked to fewer cardiac arrests

    Further data to support use of new-generation drug-eluting stents in women

    Nearly one in 10 US TAVI procedures is off label but results seem acceptable

    New hybrid operating room at Getinge Experience Center in Germany

    Haemodynamic support with Impella 2.5 heart pump significantly improves survival when initiated prior to PCI

    First European patient enrolled in study of percutaneous tricuspid repair system

    Philips to acquire Spectranetics “to accelerate expansion” in its image-guided therapy devices

    EuroPCR 2017: Study provides “first step” towards showing long-term durability of TAVI devices

    Childhood asthma may lead to thickening of left ventricle in adulthood

    Teleflex’s Vascular Solutions issues recall of Venture catheters

    Phase III Novartis study shows canakinumab reduces cardiovascular risk in heart attack survivors

    EuroPCR 2017: No risk factor identified for early stroke events in SURTAVI trial

    Nearly half of US women unaware that heart disease is their primary killer

    Negative late lumen loss at 24 months for TriReme Chocolate Heart

    Study confirms that volume matters for achieving lower in-hospital mortality after TAVI

    Italian boy becomes youngest patient bridged to transplant with the SynCardia Total Artificial Heart

    EuroPCR 2017: Switching to clopidogrel after one month reduces bleeding without increasing ischaemic events

    UK public health groups launch “Everyday Interactions” toolkit to measure professionals’ public health impact

    US FDA grants clearance to FlowGlide technology from ClearFlow

    Improving processes and outcome performance measures may be more be relevant than “arbitrary” PCI operator volume recommendations

    EuroPCR 2017: Greater risks with standard approach of dual antiplatelet therapy after TAVI

    German court awards Edwards Lifesciences co-entitlement of Neovasc’s Tiara patent application

    TVT 2017: Presentation showcases safety of Tempo temporary pacing lead

    Non-invasive approach could be used to improve valve opening functioning of biosprosthetic valves

    Venus Medtech buys InterValve

    US centres of TAVI excellence start to use newly approved Sentinel device

    ESC calls for sex-specific drug dosages of cardiovascular medication

    Risk of bleeding with aspirin in patients older than 75 is higher than thought

    EuroPCR 2017: Safety of deferring stenting in acute coronary syndrome patients is OK but could improve

    Survival benefit of early intervention in non-STEMI patients is independent of other factors

    Dose-tracking system reduces radiation exposure to patients during PCI

    HLT’s TAVI system implanted in first US patients

    OrbusNeich announces FDA clearance and launch of coronary dilatation catheters

    Sapien 3 receives expanded FDA indication for valve-in-valve procedures

    Sentinel becomes first cerebral protection device to receive FDA approval

    First procedures using Edward Lifesciences’ Inspiris Resilia aortic valve take place

    Load more

    Most read

    Bernardo Cortese

    Roxana Mehran

    Patrick Myers

    Cardiovascular News

    Write to us
    Editorial: Will Date [email protected]
    Advertising: Hannah Shiels [email protected]


    United Kingdom:

    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: [email protected]

    United States:

    BIBA Medical, North America
    155 North Wacker Drive, Suite 4250, Chicago, IL 60606
    TEL: +1 949 723 9309
    Email: [email protected]

    Terms and Conditions | Privacy Policy

    Facebook Linkedin Mail Twitter Youtube